Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - pierre+candelaria
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Novel IGE Antibodies for the Therapy of Cancer (UCLA Case No. 2021-043)
Researchers at UCLA’s David Geffen School of Medicine have designed three novel antibodies of the IgE class targeting antigens CD138, CD38, and transferrin receptor 1 (TfR1/CD71): cancer antigens present in various hematopoietic and/or solid tumors. There are several advantages of IgE class antibodies compared to the commonly used IgG class in...
Published: 6/1/2026
|
Updated: 9/10/2021
|
Inventor(s):
Manuel Penichet
,
Pierre Candelaria
,
Miguel Nava
,
Tracy Daniels-Wells
Keywords(s):
Cancer
,
Immunoglobulin G
Category(s):
Platforms > Drug Delivery > Peptide Base
,
Therapeutics > Hematology